Used as a key chiral intermediate in the synthesis of biologically active pharmaceuticals, particularly in the development of selective receptor modulators. Its piperazine core with a cyanomethyl group enables structural diversity for drug design, especially in central nervous system agents and kinase inhibitors. The tert-butoxycarbonyl (Boc) protection allows for controlled deprotection and further functionalization in multi-step syntheses. The (R)-configuration is crucial for enantioselective activity in target binding, making it valuable in asymmetric synthesis of active pharmaceutical ingredients (APIs).